Title |
Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
|
---|---|
Published in |
The Journal of Headache and Pain, May 2007
|
DOI | 10.1007/s10194-007-0373-z |
Pubmed ID | |
Authors |
Peer Tfelt-Hansen |
Abstract |
In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 11% |
Student > Master | 3 | 11% |
Student > Bachelor | 3 | 11% |
Student > Ph. D. Student | 2 | 7% |
Researcher | 2 | 7% |
Other | 6 | 21% |
Unknown | 9 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 50% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Sports and Recreations | 1 | 4% |
Neuroscience | 1 | 4% |
Chemistry | 1 | 4% |
Other | 1 | 4% |
Unknown | 9 | 32% |